1. Home
  2. BOLT vs XELB Comparison

BOLT vs XELB Comparison

Compare BOLT & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • XELB
  • Stock Information
  • Founded
  • BOLT 2015
  • XELB 2011
  • Country
  • BOLT United States
  • XELB United States
  • Employees
  • BOLT N/A
  • XELB N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • XELB Multi-Sector Companies
  • Sector
  • BOLT Health Care
  • XELB Miscellaneous
  • Exchange
  • BOLT Nasdaq
  • XELB Nasdaq
  • Market Cap
  • BOLT 22.6M
  • XELB 19.0M
  • IPO Year
  • BOLT 2021
  • XELB N/A
  • Fundamental
  • Price
  • BOLT $0.51
  • XELB $0.43
  • Analyst Decision
  • BOLT Hold
  • XELB
  • Analyst Count
  • BOLT 5
  • XELB 0
  • Target Price
  • BOLT $1.25
  • XELB N/A
  • AVG Volume (30 Days)
  • BOLT 186.2K
  • XELB 376.5K
  • Earning Date
  • BOLT 11-12-2024
  • XELB 12-20-2024
  • Dividend Yield
  • BOLT N/A
  • XELB N/A
  • EPS Growth
  • BOLT N/A
  • XELB N/A
  • EPS
  • BOLT N/A
  • XELB N/A
  • Revenue
  • BOLT $9,779,000.00
  • XELB $9,337,000.00
  • Revenue This Year
  • BOLT $9.87
  • XELB N/A
  • Revenue Next Year
  • BOLT N/A
  • XELB $74.82
  • P/E Ratio
  • BOLT N/A
  • XELB N/A
  • Revenue Growth
  • BOLT 35.86
  • XELB N/A
  • 52 Week Low
  • BOLT $0.48
  • XELB $0.33
  • 52 Week High
  • BOLT $1.56
  • XELB $1.70
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 41.39
  • XELB 37.11
  • Support Level
  • BOLT $0.50
  • XELB $0.42
  • Resistance Level
  • BOLT $0.55
  • XELB $0.48
  • Average True Range (ATR)
  • BOLT 0.04
  • XELB 0.05
  • MACD
  • BOLT -0.00
  • XELB 0.00
  • Stochastic Oscillator
  • BOLT 13.04
  • XELB 17.45

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: